Search - tctmd.com

Displaying 461 - 480 of 635

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Case Presentation: A Case of Managing Paravalvular Regurgitation During TAVR

Presenter: Omar Khalique

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ten Tips to Achieve Optimal Percutaneous Transfemoral Access and Closure for TAVR

Presenter: Isaac George, James M. McCabe, Jonathon M. White

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

TCT 8: Aortic Paravalvular Amplatzer Plug Extractions, Valve in Valve TAVR and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presentation The Structural Heart Disease Summit 2018

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presenter: Ashish Pershad, Mehul Patel

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presenter: Ashish Pershad, Mehul Patel

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Impact of Paravalvular Regurgitation After TAVR on LV Geometry: A Serial Echo Study

Presenter: Jung-Min Ahn

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Presenter: Philippe Pibarot

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcaval TAVR Complicated by Double Wammy

Presenter: Ashish Pershad, Waleed Alharbi, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Unexpected Apparition - or - Old Valves Die Hard

Presenter: Ashish Pershad, Takehiro Yamashita, MD

June 21, 2018

Advertisement

Case Presentation: A Case of Managing Paravalvular Regurgitation During TAVR

Ten Tips to Achieve Optimal Percutaneous Transfemoral Access and Closure for TAVR

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Impact of Paravalvular Regurgitation After TAVR on LV Geometry: A Serial Echo Study

NO: The Data Are Weak and the Costs Are Prohibitive!

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

YES: Review of ALL the Data and Common Sense Tell the Story!

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Case #3: A Small (Undersized) Surgical Bioprosthesis

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Transcaval TAVR Complicated by Double Wammy

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Case #1: A Poorly Visible Surgical Bioprosthesis

An Unexpected Apparition - or - Old Valves Die Hard

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content